STANDARD BIOTOOLS INC (LAB) Stock Analyst Ratings
USA - NASDAQ:LAB - US34385P1084 - Common Stock
1.2 USD
+0.05 (+4.35%)
1.2 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 77% to LAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.81. This target is 50.88% above the current price.
LAB was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about LAB.
In the previous month the buy percentage consensus was at a similar level.
LAB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-27 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2024-10-31 | TD Cowen | Maintains | Buy -> Buy |
| 2024-08-01 | TD Cowen | Maintains | Buy -> Buy |
| 2024-04-16 | TD Cowen | Initiate | Buy |
| 2024-04-04 | Jefferies | Initiate | Buy |
| 2023-07-12 | Keybanc | Initiate | Overweight |
STANDARD BIOTOOLS INC / LAB FAQ
What is the average price target for STANDARD BIOTOOLS INC (LAB) stock?
7 analysts have analysed LAB and the average price target is 1.81 USD. This implies a price increase of 50.88% is expected in the next year compared to the current price of 1.2.
Can you provide the consensus rating for STANDARD BIOTOOLS INC stock?
The consensus rating for STANDARD BIOTOOLS INC (LAB) is 77.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for LAB stock?
The number of analysts covering STANDARD BIOTOOLS INC (LAB) is 7.